Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Neurodegenerative Drugs
... CAGR of 6.8% over the analysis period 2024-2030. Dopamine Agonist, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$25.7 Billion by the end of the analysis ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
U.S. Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices), By Therapy Area (Stroke, Parkinson’s Disease),- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
... CAGR of 13.2% during the forecast period 2024 to 2033. U.S. Neurorehabilitation Devices Market Key Takeaways: The neurorobotics segment dominated and accounted for the largest revenue share of 36.15% in 2023. The wearable devices segment ... Read More
-
2025 Diseases of the Nervous System Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the nervous system ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2025-2033
... market is experiencing robust growth, driven by the increasing prevalence of chronic and neurological disorders, imposition of favorable regulatory environment, rising expenditure on healthcare, significant advancements in device technology, and growing demand for minimally invasive ... Read More
-
Neurorehabilitation Devices Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Parkinson’s Disease Therapeutics Market - 2025-2033
... at a CAGR of 8.1% during the forecast period 2025-2033. The Parkinson’s disease treatment market continues to grow as the prevalence of the condition rises, the global population ages, and medical research advances. This progressive ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to boost development of new drugs is expected to impel market growth. National Institute of Neurological Disorders and Stroke provides funding opportunities ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the end ... Read More
-
Parkinson’s Disease Drugs
... at a CAGR of 6.5% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$4.6 Billion by the end of the ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\\\'s Disease, Alzheimer\\\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Medical Foods Market Size, Share, and Outlook, 2025 Report- By Route of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid, Other), By Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Severe Protein Allergy, Cancer, Cachexia, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Foods segments across 22 countries from 2021 to 2032. ... Read More
-
Neurology Clinical Trials Market Size, Share, and Outlook, 2025 Report- By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurology Clinical Trials segments across 22 countries ... Read More
-
Neurorehabilitation Devices Market Size, Share, and Outlook, 2025 Report- By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Therapy Area (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurorehabilitation Devices segments across 22 countries from 2021 to 2032. ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Active Wheelchair Market Size, Share, and Outlook, 2025 Report- By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Active Wheelchair segments across 22 countries from 2021 to 2032. ... Read More
-
Continence Care Market Size, Share, and Outlook, 2025 Report- By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Continence Care segments across 22 countries from 2021 to 2032. ... Read More
-
Deep Brain Stimulation in Parkinson's Disease Market Size, Share, and Outlook, 2025 Report- By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), 2021-2032
... Parkinson's Disease market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Asia Pacific Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
... to 2031. Strategic Initiatives by Market Players Boost Asia Pacific Neurorehabilitation Devices Market Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand ... Read More
-
North America Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
... to 2031. Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation Devices Market Patients suffering from neurological diseases such as stroke, Parkinson’s disease, multiple sclerosis (MS), Alzheimer's disease, and cerebral palsy require neurorehabilitation devices to ... Read More
-
Europe Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
... 2031. Growing Number of Clinical Studies on Neurorehabilitation Devices Drives Europe Neurorehabilitation Devices Market Clinical studies validate the safety and effectiveness of newly developed neurorehabilitation devices. They provide evidence that neurorehabilitation devices help improve the ... Read More
-
Parkinson's Disease Monitoring Device Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type
... Essential in neurology, they feature real-time data collection and portability. Available as wrist monitors, ankle monitors, and other types, they serve hospitals and clinics. The market is driven by rising Parkinson’s prevalence, aging populations, and ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer\\\'s Disease, Parkinson\\\'s Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... sigma-1 receptor forms heterodimers with many other membrane receptors and, as such, influences multiple cellular pathways and physiological processes. Blarcamesine reportedly binds the sigma-1 receptor in the high nanomolar and the muscarinic receptor in the ... Read More